Scope Fluidics SA GPW:SCP:

  • BACTEROMIC SIGNS AGREEMENT WITH COMAC MEDICAL FOR CLINICAL TRIALS OF BACTEROMIC PBC PANEL

  • ESTIMATED COST OF CLINICAL TRIALS NOT TO EXCEED EUR 1 MILLION

  • IVDR CERTIFICATION FOR BACTEROMIC PBC PANEL EXPECTED IN 2027